

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition


(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.


Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional


Recipharm To Make No Further Changes To Consort Medical Offer


Recipharm Extends Consort Medical Offer Deadline To February 4


Recipharm Buys 10% Of Takeover Target Consort Medical


Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle


(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.